title: Development of the first generation c-met kinase inhibitors: beginning of a path to a new treatment for cancer.
authors.affiliation: Metabolex, Inc., Biology, Hayward, CA 94404, USA. xwang720@yahoo.com
authors.forename: Xueyan
authors.initials: X
authors.lastname: Wang
authors.forename: Gerald
authors.initials: G
authors.lastname: McMahon
authors.forename: Kenneth E
authors.initials: KE
authors.lastname: Lipson
mesh_terms: D017228:Hepatocyte Growth Factor / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D006801:Humans; D009361:Neoplasm Invasiveness; D009369:Neoplasms / Q000473:pathology*; D019859:Proto-Oncogene Proteins c-met / Q000037:antagonists & inhibitors* / Q000378:metabolism*
chemical_list: D017228:Hepatocyte Growth Factor; D019859:Proto-Oncogene Proteins c-met